Molecular docking analysis suggested that MDA may deactivate SOD1 by interacting with its active site, indicating that impaired antioxidant defences, particularly through the deactivation of SOD1 by MDA, may play a critical role in the progression of MASLD. This evidence concerns the gene SOD1 and metabolic dysfunction-associated steatotic liver disease.